MHC Class I Assembly and Antigen Presentation Pathway

Added:

Cross-Presentation of Exogenous Antigens

While the classical MHC class I pathway dictates that these molecules exclusively present endogenous (intracellularly synthesized) viral or self-proteins, the phenomenon of 'cross-presentation' challenges this strict dichotomy. In cross-presentation, specialized antigen-presenting cells—chiefly dendritic cells—acquire exogenous (extracellular) antigens from dying infected cells or tumors, process them, and load them onto MHC class I molecules to activate CD8+ cytotoxic T cells. This pathway bypasses the traditional rule that exogenous antigens are strictly reserved for MHC class II presentation. It represents a vital alternative mechanism, crucial for initiating immune responses against viruses and tumors that do not directly infect or transform antigen-presenting cells themselves.

Basic cell biology, specifically the structure and function of the Endoplasmic Reticulum (ER) and the secretory pathway where membrane proteins are processed.
The fundamentals of the adaptive immune system, including the primary roles of T lymphocytes (T cells) in cellular immunity.
The ubiquitin-proteasome system, which is responsible for degrading cellular proteins into the short peptide fragments that are loaded onto MHC Class I.
An introductory understanding of MHC (Major Histocompatibility Complex) molecules and their primary function in distinguishing self from non-self.
The MHC Class II antigen presentation pathway (the exogenous pathway) and how it compares and contrasts with the MHC Class I pathway.
The mechanics of T-cell receptor (TCR) binding and how CD8+ cytotoxic T cells recognize the MHC-I peptide complex to initiate target cell apoptosis.
Viral evasion mechanisms, specifically how pathogens like Herpes Simplex Virus or Adenovirus disrupt MHC Class I assembly and presentation to escape immune detection.
Clinical applications of MHC Class I presentation in cancer immunotherapy (tumor neoantigens) and the principles of transplant immunology (graft rejection).
177.4K views2.4Klikes5:19@immunologytoronto3083Original Release: 2012-09-14

MHC class I molecules are assembled in the endoplasmic reticulum through a quality-controlled process involving calnexin, ERP57, beta-2 microglobulin, and the peptide loading complex (PLC), which includes TAP and tapasin; these molecules bind viral or self peptides, and only those containing viral peptides are recognized by cytotoxic T cells, triggering cell destruction to eliminate infected cells.